BRAC Bank finances Eskayef to expand insulin production
ইনসুলিন উৎপাদন বাড়াতে এসকেএফকে অর্থায়ন ব্র্যাক ব্যাংকের
The financing supports greater availability of the essential medicine in Bangladesh and abroad.
Key points tap a point to see its source
-
BRAC Bank has extended financing to Eskayef Pharmaceuticals (SK+F) to expand its insulin production capacity, The Daily Star reports. The Daily Star
reporting The Daily Star — BRAC Bank finances Eskayef to expand insulin production read the original ↗ (thedailystar.net) - The expansion is intended to improve availability of insulin in Bangladesh and in international markets.
BRAC Bank has extended financing support to Eskayef Pharmaceuticals Ltd, also known as SK+F, to expand its insulin production capacity, The Daily Star reports. The financing is aimed at supporting greater availability of the essential medicine in Bangladesh and in international markets.
Ask Nirikh
Answers are generated only from Nirikh's published stories and show their sources. Not medical, legal or financial advice.
Related
-
Leadership void leaves Islami Bank's major decisions stalled
The country's largest private lender is in limbo, according to The Daily Star.
-
Standard Chartered Bangladesh plans to close its retail banking operation
The bank has informally asked some lenders to prepare for a formal process to acquire the business, The Business Standard reports.
-
Sonali Bank's first-half profit jumps 193% to Tk 1,878 crore
Treasury gains and lower provisions drove the state-owned lender's earnings, The Business Standard reports.
-
Three more banks join Bangladesh Bank refinance schemes for green, export and ICT lending
Mercantile, Citizens and NRB Bank signed participation agreements, with Mercantile citing schemes totalling Tk 5,000 crore.